Agex Therapeutics Inc.
13F holders, Q2 2024 (June 30)1holders
$1.62avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Agex Therapeutics Inc. in their 13F filings. The largest holder was Strategic Investment Solutions, Inc. ($405).
- Company
- Agex Therapeutics Inc.
- CUSIP
- 00848H108
- Latest filing quarter
- Q2 2024
Total Exit/New Position Q2 2024
No earlier quarter to compare with.
Ownership 1 holders
| Strategic Investment Solutions, Inc. | 0.00% | — | 250 | $405 |
"% of holder's portfolio" is AGEX THERAPEUTICS INC's weight in each manager's 13F, not the share of Agex Therapeutics Inc. the manager owns.